 |
1-(2-Nitro-imidazolyl)-3-[18F]fluoro-2-propanol;1H-1-(3-[18F]fluoro-2-hydroxypropyl)-2-nitroimidazole |
|---|---|
| Trade Name | |
| Orphan Indication | As a diagnostic for clinical management of soft tissue sarcoma, including rhabdomyosarcoma |
| USA Market Approval | USA |
| USA Designation Date | 2016-01-06 00:00:00 |
| Sponsor | Advanced Imaging Projects, LLC;7947 Brookside Ct.;Lake Worth, Florida, 33467 |
